Cargando…
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/ https://www.ncbi.nlm.nih.gov/pubmed/31922953 http://dx.doi.org/10.3201/eid2603.190997 |
_version_ | 1783501852111798272 |
---|---|
author | Campbell, Jonathon R. Falzon, Dennis Mirzayev, Fuad Jaramillo, Ernesto Migliori, Giovanni Battista Mitnick, Carole D. Ndjeka, Norbert Menzies, Dick |
author_facet | Campbell, Jonathon R. Falzon, Dennis Mirzayev, Fuad Jaramillo, Ernesto Migliori, Giovanni Battista Mitnick, Carole D. Ndjeka, Norbert Menzies, Dick |
author_sort | Campbell, Jonathon R. |
collection | PubMed |
description | International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve consistency and utility for future evidence-based recommendations. We highlight critical stages in data collection at which improvements to uniformity, accuracy, and completeness could add value to IPD quality. Through a repetitive development process, we suggest essential patient- and treatment-related characteristics that should be collected by prospective contributors of observational IPD in MDR/RR TB. |
format | Online Article Text |
id | pubmed-7045826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-70458262020-03-07 Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis Campbell, Jonathon R. Falzon, Dennis Mirzayev, Fuad Jaramillo, Ernesto Migliori, Giovanni Battista Mitnick, Carole D. Ndjeka, Norbert Menzies, Dick Emerg Infect Dis Online Report International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve consistency and utility for future evidence-based recommendations. We highlight critical stages in data collection at which improvements to uniformity, accuracy, and completeness could add value to IPD quality. Through a repetitive development process, we suggest essential patient- and treatment-related characteristics that should be collected by prospective contributors of observational IPD in MDR/RR TB. Centers for Disease Control and Prevention 2020-03 /pmc/articles/PMC7045826/ /pubmed/31922953 http://dx.doi.org/10.3201/eid2603.190997 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Online Report Campbell, Jonathon R. Falzon, Dennis Mirzayev, Fuad Jaramillo, Ernesto Migliori, Giovanni Battista Mitnick, Carole D. Ndjeka, Norbert Menzies, Dick Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title | Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title_full | Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title_fullStr | Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title_full_unstemmed | Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title_short | Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis |
title_sort | improving quality of patient data for treatment of multidrug- or rifampin-resistant tuberculosis |
topic | Online Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045826/ https://www.ncbi.nlm.nih.gov/pubmed/31922953 http://dx.doi.org/10.3201/eid2603.190997 |
work_keys_str_mv | AT campbelljonathonr improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT falzondennis improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT mirzayevfuad improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT jaramilloernesto improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT migliorigiovannibattista improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT mitnickcaroled improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT ndjekanorbert improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis AT menziesdick improvingqualityofpatientdatafortreatmentofmultidrugorrifampinresistanttuberculosis |